Get started
Author

Fernanda Picozzi

Observed names: F. Picozzi, Picozzi, Fernanda, fernanda picozzi
ORCID: 0009-0007-7386-6250
Observed ORCID: 0009-0007-7386-6250
OpenAlex ID: A5066743751
Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
2019 · Carlo Buonerba, Simona Iaccarino, et al. · Cancers · 22
PDF
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives
2024 · Alessandra Bracigliano, Antonella Lucia Marretta, et al. · Pharmaceuticals · 17
PDF
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
2020 · Margaret Ottaviano, Marcello Curvietto, et al. · Journal for ImmunoTherapy of Cancer · 17
PDF
Extraskeletal Ewing’s sarcoma of the mediastinum: Case report
2023 · Aldo Caltavituro, Roberto Buonaiuto, et al. · Frontiers in Oncology · 11
PDF
Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network
2022 · Giacomo G. Baldi, Salvatore Lo Vullo, et al. · Cancer · 11
Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic
2022 · Erica Pietroluongo, Pietro De Placido, et al. · Mediastinum · 9
FAP-α in soft tissue and bone sarcomas: A new potential diagnostic and therapeutic biomarker in the era of precision medicine
2025 · Alessandra Bracigliano, Ottavia Clemente, et al. · Critical Reviews in Oncology/Hematology · 6
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
2021 · Margaret Ottaviano, Mario Giuliano, et al. · Frontiers in Oncology · 6
PDF
Low-dose oral etoposide is an active option for patients with heavily pre-treated thymic epithelial tumors.
2020 · Margaret Ottaviano, Marianna Tortora, et al. · Journal of Clinical Oncology · 5
A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial
2024 · C. von Arx, G. Della Vittoria Scarpati, et al. · ESMO Open · 4
Mediastinal soft tissue sarcoma: dark sides and future lights
2020 · Giovannella Palmieri, Marianna Tortora, et al. · Mediastinum · 4
1200P A phase II single-arm interventional trial evaluating the activity and safety of CABOzantinib (CBZ) plus TEMozolomide (TMZ) in lung and gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) progressed after SSA therapy, everolimus, sunitinib or PRRT: CABOTEM Trial
2023 · O. Clemente, N. Starita, et al. · Annals of Oncology · 3
PDF
AB008. Synchronous thymic and breast malignancies: a single institutional experience
2021 · Pietro De Placido, Rocco Morra, et al. · Mediastinum · 2
Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling
2021 · Liliana Montella, Margaret Ottaviano, et al. · Biomedicines · 2
PDF
Differential serum binding patterns predicting healthy subjects and cancer patients
2026 · Beatrice Cavalluzzo, Biancamaria Cembrola, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study
2026 · Mauro Cives, Giuseppina Della Vittoria Scarpati, et al. · Nature Communications · 1
PDF
A systematic review and meta-analysis of pazopanib efficacy and adverse effects in sarcomas
2026 · Fernanda Picozzi, Alessandro Ottaiano, et al. · Journal of Translational Medicine · 1
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME)
2025 · Chiara Catania, Sara Manglaviti, et al. · Cancers · 1
PDF
AB009. Pitfalls in mediastinal masses diagnosis
2021 · Aldo Caltavituro, Roberto Buonaiuto, et al. · Mediastinum · 1
Anti-EGFR target therapy in advanced thymic epithelial tumors.
2019 · Mario Giuliano, Margaret Ottaviano, et al. · Journal of Clinical Oncology · 1
Systems serology identifies differential pan-viral seroreactivity profiles associated with healthy aging and cancer
2026 · Beatrice Cavalluzzo, Biancamaria Cembrola, et al. · Cell Death and Disease
Peptide optimization to improve antigen presentation and antitumor responses in sarcoma
2026 · Angela Mauriello, Concetta Ragone, et al. · Frontiers in Immunology
PDF
Integrated transcriptomic analysis identifies Paternally Expressed Gene 10 as a novel candidate biomarker associated with aggressive features in liposarcoma
2026 · Turiello Roberta, Scognamiglio Giosuè, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Raw data supporting "Peptide Optimization to Improve Antigen Presentation and Antitumor Responses in Sarcoma"
2026 · MAURIELLO, ANGELA, Ragone, Concetta, et al. · Zenodo (CERN European Organization for Nuclear Research)
Genomic profiling of a DICER1-wildtype thyroblastoma reveals AGK-BRAF fusion, EIF1AX duplication, and TERT promoter mutations: integrated genomic and pathway analysis
2026 · Alberto Gualandi, Fernanda Picozzi, et al. · Frontiers in Endocrinology
Works count: 40
Citation count: 125
H-index: 6
I10-index: 5
Year
Topic
Type